Teicoplanin 99%: Your Advanced Pharmaceutical Intermediate
Discover the high-purity glycopeptide antibiotic essential for combating severe gram-positive bacterial infections.
Get a Quote & SampleProduct Core Value
Teicoplanin
Teicoplanin is a high-purity glycopeptide antibiotic that plays a crucial role in modern healthcare. With a purity exceeding 99%, it is specifically engineered as a chemical intermediate for pharmaceutical applications, targeting severe infections caused by gram-positive bacteria, including challenging drug-resistant strains like MRSA. Its reliable performance makes it an indispensable component for therapeutic formulations.
- Benefit from Teicoplanin antibiotic 99% purity for your demanding pharmaceutical needs.
- Utilize this glycopeptide antibiotic for gram-positive infections, ensuring broad-spectrum efficacy.
- Incorporate Teicoplanin for effective MRSA treatment, a key chemical intermediate in combating resistant pathogens.
- Source high-purity Teicoplanin powder for sale, a vital pharmaceutical raw material for healthcare supplements.
Advantages You Gain
Exceptional Purity and Potency
Achieve superior therapeutic outcomes with our Teicoplanin, boasting 99% purity for potent activity against gram-positive bacteria and MRSA strains.
Reliable Pharmaceutical Intermediate
Source a dependable pharmaceutical raw material, crucial for developing effective healthcare supplements and treatments.
Efficient In-Stock Capacity and Fast Delivery
Ensure timely project completion with our ample in-stock capacity and commitment to fast delivery, supporting your production schedules.
Key Applications
Antibiotic Therapy
Administer Teicoplanin as a vital component in IV or IM injections to treat severe infections effectively, showcasing its role as a key antibiotic intermediate.
Healthcare Supplements
Formulate high-quality healthcare supplements leveraging the beneficial properties of Teicoplanin powder, catering to health-conscious consumers.
MRSA Treatment Formulations
Develop advanced treatments for MRSA and other resistant gram-positive infections, relying on Teicoplanin's proven efficacy.
Pharmaceutical Research
Utilize Teicoplanin CAS 61036-62-2 in research and development to explore new therapeutic avenues for bacterial infections.